Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Mueller, Emily L ^a,b   Walkovich, Kelly J ^c   Mody, Rajen ^c   Gebremariam, Achamyeleh ^d   Davis, Matthew M ^c,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adolescent; Child; Febrile neutropenia; Oncology; Supportive care

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ACUTE OTITIS MEDIA; ADOLESCENT; ADULT; ARTICLE; BONE CANCER; CANCER PATIENT; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FEVER; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HODGKIN DISEASE; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ICD-9; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; NEUROBLASTOMA; NEUTROPENIA; NONHODGKIN LYMPHOMA; OVARY TUMOR; RISK FACTOR; SOFT TISSUE SARCOMA; TESTIS TUMOR; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; CHEMICALLY INDUCED; MALE; NEOPLASMS; PATHOLOGY; PATHOPHYSIOLOGY; PEDIATRICS; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HOSPITALIZATION; HUMANS; MALE; NEOPLASMS; NEUTROPENIA; PATIENT DISCHARGE; PEDIATRICS; UNITED STATES;

EID: 84929392076     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1413-8     Document Type: Article

References (32)

1. Mullen CA. Which children with fever and neutropenia can be safely treated as outpatients? Br J Haematol. 2001;112(4):832-7.
2. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64(2):328-40.
3. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Infectious diseases society of America: clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52(4):e56-93.
4. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med. 1993;328(18):1323-32.
5. Basu SK, Fernandez ID, Fisher SG, Asselin BL, Lyman GH. Length of stay and mortality associated with febrile neutropenia among children with cancer. J Clin Oncol. 2005;23(31):7958-66.
6. Overview of the Kids' Inpatient Database (KID). Healthcare Cost and Utilization Project (HCUP): 2009. [ http://www.hcup-us.ahrq.gov/kidoverview.jsp ]
7. Benneyworth BD, Gebremariam A, Clark SJ, Shanley TP, Davis MM. Inpatient health care utilization for children dependent on long-term mechanical ventilation. Pediatrics. 2011;127(6):e1533-1541.
8. Caskey RN, Davis MM. Differences associated with age, transfer status, and insurance coverage in end-of-life hospital care for children. J Hosp Med. 2008;3(5):376-83.
9. Odetola FO, Gebremariam A, Freed GL. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics. 2007;119(3):487-94.
10. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307(18):1934-40.
11. Setty BA, O'Brien SH, Kerlin BA. Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases. Pediatr Blood Cancer. 2012;59(2):258-64.
12. Woolford SJ, Gebremariam A, Clark SJ, Davis MM. Persistent gap of incremental charges for obesity as a secondary diagnosis in common pediatric hospitalizations. J Hosp Med. 2009;4(3):149-56.
13. Zickafoose JS, Benneyworth BD, Riebschleger MP, Espinosa CM, Davis MM. Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States. Arch Pediatr Adolesc Med. 2012;166(4):350-5.
14. Orudjev E, Lange BJ. Evolving concepts of management of febrile neutropenia in children with cancer. Med Pediatr Oncol. 2002;39(2):77-85.
15. Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, Fisher B, et al. International pediatric fever neutropenia guideline panel: guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol. 2012;30(35):4427-38.
16. Macy ML, Stanley RM, Sasson C, Gebremariam A, Davis MM. High turnover stays for pediatric asthma in the United States: analysis of the 2006 kids' inpatient database. Med Care. 2010;48(9):827-33.
17. Annual Estimates of the Resident Population by Sex and Five-Year Age Groups for the United States: April 1, 2000 to July 1, 2009 (NC-EST2009-01) U.S. Census Bureau, Population Division Release Date: June 2010. [ www.census.gov ]
18. Consumer Price Index Inflation Calculator. [ http://data.bls.gov/cgi-bin/cpicalc.pl ]
19. Orkin SH. Oncology of infancy and childhood. Philadelphia: Saunders Elsevier; 2009.
20. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83-103.
21. Alexander N. Question 3. Do Portacaths or Hickman lines have a higher risk of catheter-related infections in children with leukaemia? Arch Dis Child. 2010;95(3):239-41.
22. Benites EC, Cabrini DP, Silva AC, Silva JC, Catalan DT, Berezin EN, et al. Acute respiratory viral infections in pediatric cancer patients undergoing chemotherapy. J Pediatr (Rio J). 2014;90(4):370-6.
23. Teuffel O, Amir E, Alibhai SM, Beyene J, Sung L. Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer. Pediatrics. 2011;127(2):e279-286.
24. Klastersky J, Paesmans M. The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer. 2013;21(5):1487-95.
25. Vidal, Ben dor I, Paul M, Pokroy E, Soares-Weiser K, Leibovici L. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Cochrane Database Syst Rev. 2013;10:CD003992.
26. Manji A, Beyene J, Dupuis LL, Phillips R, Lehrnbecher T, Sung L. Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children-a systematic review of prospective trials. Support Care Cancer. 2012;20(6):1135-45.
27. Phillips RS, Lehrnbecher T, Alexander S, Sung L. Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia. PLoS One. 2012;7(5), e38300.
28. te Poele EM, Tissing WJ, Kamps WA, de Bont ES. Risk assessment in fever and neutropenia in children with cancer: what did we learn? Crit Rev Oncol Hematol. 2009;72(1):45-55.
29. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol. 1997;99(3):580-8.
30. Baorto EP, Aquino VM, Mullen CA, Buchanan GR, DeBaun MR. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer. 2001;92(4):909-13.
31. Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis. 2007;45(10):1296-304.
32. Biondi EA, Mischler M, Jerardi KE, Statile AM, French J, Evans R, Lee V, Chen C, Asche C, Ren J, Shah SS, for the Pediatric Research in Inpatient Settings Network: Blood Culture Time to Positivity in Febrile Infants With Bacteremia. JAMA pediatrics 2014;168(9):844-849.